{"product_id":"test-urinaire-drugdiag®-6t2-nouvelles-drogues-de-synthese","title":"Test Urinario 6 Drogas Drugdiag® 6T2 - Nuevas Drogas de síntesis","description":"\u003cstyle\u003e\n\/* =========================================================\n   AMA Prévention — B-SAFE\n   Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n   Sans JS — prêt Shopify\n   ========================================================= *\/\n\n.ama-bsafe-2026 {\n  --ama-blue: #004C96;\n  --ama-blue-deep: #003B78;\n  --ama-blue-night: #00325f;\n  --ama-orange: #FE4B09;\n  --ama-text: #004C96;\n  --ama-muted: #667085;\n  --ama-border: #dbe6f2;\n  --ama-soft: #f6f9fd;\n  --ama-white: #ffffff;\n\n  width: 100%;\n  max-width: 1180px;\n  margin: 0 auto;\n  padding: 0;\n  font-family: inherit;\n  color: var(--ama-text);\n  background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n  box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n  min-width: 0;\n}\n\n.ama-bsafe-panel {\n  width: 100%;\n  position: relative;\n  overflow: hidden;\n  isolation: isolate;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 28px;\n  background:\n    radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n    radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n    linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n  box-shadow:\n    0 22px 55px rgba(0, 76, 150, 0.10),\n    inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n  width: 100%;\n  padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n  margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n  display: inline-flex;\n  align-items: center;\n  gap: 8px;\n  margin-bottom: 14px;\n  padding: 7px 12px;\n  border-radius: 999px;\n  background: rgba(0, 76, 150, 0.08);\n  color: var(--ama-blue);\n  font-size: 12px;\n  font-weight: 900;\n  letter-spacing: 0.04em;\n  text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n  content: \"\";\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n  margin: 0 0 16px;\n  color: var(--ama-blue);\n  font-size: clamp(30px, 4vw, 46px);\n  line-height: 1.08;\n  font-weight: 900;\n  letter-spacing: -0.045em;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n  margin: 0 0 16px;\n  color: var(--ama-text);\n  font-size: clamp(16px, 1.4vw, 18px);\n  line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n  color: var(--ama-blue);\n  font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n  display: flex;\n  flex-wrap: wrap;\n  gap: 10px;\n  margin-top: 26px;\n  padding: 14px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 20px;\n  background: rgba(255, 255, 255, 0.72);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n  display: inline-flex;\n  align-items: center;\n  gap: 8px;\n  flex: 1 1 230px;\n  padding: 10px 12px;\n  border-radius: 999px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  border: 1px solid rgba(0, 76, 150, 0.10);\n  color: var(--ama-blue);\n  font-size: 14px;\n  font-weight: 850;\n  line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n  content: \"\";\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n  flex-shrink: 0;\n}\n\n\/* =========================================================\n   Accordéon principal\n   Fermé : bleu nuit\n   Ouvert : clair + contenu dans le même bloc\n   ========================================================= *\/\n\n.ama-bsafe-accordion {\n  width: 100%;\n  max-width: 920px;\n  margin: 0 auto;\n  display: grid;\n  gap: 12px;\n}\n\n.ama-bsafe-item {\n  border-radius: 24px;\n  overflow: hidden;\n  background:\n    linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n  border: 1px solid rgba(0, 76, 150, 0.26);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.22),\n    inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n    0 16px 36px rgba(0, 76, 150, 0.17);\n  transition:\n    background 220ms ease,\n    box-shadow 220ms ease,\n    border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n  background:\n    radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n    linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n  border-color: rgba(0, 76, 150, 0.14);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.98),\n    0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n  position: relative;\n  min-height: 66px;\n  padding: 14px 58px 14px 18px;\n  display: flex;\n  align-items: center;\n  cursor: pointer;\n  list-style: none;\n  user-select: none;\n  -webkit-tap-highlight-color: transparent;\n  color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n  display: none;\n}\n\n.ama-bsafe-item[open] summary {\n  color: var(--ama-blue);\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n  border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n  content: \"+\";\n  position: absolute;\n  right: 16px;\n  top: 50%;\n  width: 36px;\n  height: 36px;\n  transform: translateY(-50%);\n  border-radius: 999px;\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  color: #ffffff;\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n  border: 1px solid rgba(255, 255, 255, 0.26);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.30),\n    0 10px 22px rgba(0, 0, 0, 0.14);\n  font-size: 22px;\n  font-weight: 760;\n  line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n  content: \"−\";\n  color: var(--ama-blue);\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n  border-color: rgba(0, 76, 150, 0.10);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.96),\n    0 8px 18px rgba(0, 76, 150, 0.10);\n  font-size: 24px;\n  font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n  .ama-bsafe-item:not([open]):hover {\n    box-shadow:\n      inset 0 1px 0 rgba(255, 255, 255, 0.26),\n      inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n      0 20px 44px rgba(0, 76, 150, 0.22);\n  }\n\n  .ama-bsafe-item[open]:hover {\n    box-shadow:\n      inset 0 1px 0 rgba(255, 255, 255, 0.98),\n      0 18px 42px rgba(0, 76, 150, 0.13);\n  }\n}\n\n.ama-bsafe-acc-title {\n  display: block;\n  font-size: 16px;\n  line-height: 1.18;\n  font-weight: 800;\n  letter-spacing: -0.018em;\n  color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n  display: block;\n  margin-top: 3px;\n  font-size: 13px;\n  line-height: 1.24;\n  font-weight: 650;\n  letter-spacing: -0.01em;\n  color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n  color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n  padding: clamp(20px, 4vw, 34px);\n  background: transparent;\n  animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n  from {\n    opacity: 0;\n    transform: translateY(5px);\n  }\n\n  to {\n    opacity: 1;\n    transform: translateY(0);\n  }\n}\n\n\/* =========================================================\n   Contenu\n   ========================================================= *\/\n\n.ama-bsafe-content h2 {\n  margin: 0 0 18px;\n  color: var(--ama-blue);\n  font-size: clamp(24px, 3vw, 36px);\n  line-height: 1.10;\n  font-weight: 900;\n  letter-spacing: -0.04em;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n  content: \"\";\n  display: block;\n  width: 78px;\n  height: 4px;\n  margin-top: 14px;\n  border-radius: 999px;\n  background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n  margin: 0 0 10px;\n  color: var(--ama-blue);\n  font-size: clamp(18px, 1.7vw, 23px);\n  line-height: 1.18;\n  font-weight: 900;\n  letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n  margin: 0 0 18px;\n  color: var(--ama-text);\n  font-size: 16px;\n  line-height: 1.72;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n  display: grid;\n  grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n  gap: 18px;\n  margin: 26px 0;\n}\n\n.ama-bsafe-card {\n  position: relative;\n  min-height: 150px;\n  padding: 24px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 22px;\n  background: rgba(255, 255, 255, 0.86);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  overflow-wrap: break-word;\n  transition:\n    transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n  margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n  .ama-bsafe-card:hover,\n  .ama-bsafe-substance-row:hover {\n    transform: translateY(-2px);\n    border-color: rgba(254, 75, 9, 0.32);\n    background: #ffffff;\n    box-shadow:\n      0 16px 34px rgba(0, 76, 150, 0.10),\n      inset 0 1px 0 rgba(255, 255, 255, 0.95);\n  }\n}\n\n.ama-bsafe-substance-list {\n  display: grid;\n  gap: 12px;\n  margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n  width: 100%;\n  display: flex;\n  align-items: center;\n  flex-wrap: wrap;\n  gap: 12px 18px;\n  padding: 16px 18px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 20px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  transition:\n    transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  flex: 0 0 130px;\n  width: 130px;\n  min-width: 130px;\n  max-width: 130px;\n  min-height: 38px;\n  padding: 7px 14px;\n  border-radius: 999px;\n  background: rgba(0, 76, 150, 0.08);\n  color: var(--ama-blue);\n  font-size: 15px;\n  font-weight: 950;\n  letter-spacing: -0.01em;\n  text-align: center;\n}\n\n.ama-bsafe-substance-main {\n  flex: 1 1 420px;\n  min-width: min(100%, 320px);\n  color: var(--ama-text);\n  font-size: 15px;\n  line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  flex: 0 0 auto;\n  margin-left: auto;\n  min-height: 34px;\n  padding: 6px 12px;\n  border-radius: 999px;\n  background: rgba(254, 75, 9, 0.08);\n  color: var(--ama-orange);\n  font-size: 13px;\n  font-weight: 900;\n  white-space: nowrap;\n}\n\n.ama-bsafe-list {\n  list-style: none;\n  padding: 0;\n  margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n  position: relative;\n  padding: 15px 18px 15px 44px;\n  margin-bottom: 10px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 18px;\n  background: rgba(255, 255, 255, 0.84);\n  box-shadow:\n    0 6px 18px rgba(0, 76, 150, 0.035),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  color: var(--ama-text);\n  font-size: 15px;\n  line-height: 1.62;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n  content: \"\";\n  position: absolute;\n  left: 18px;\n  top: 22px;\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n  margin: 22px 0;\n  padding: 18px 20px;\n  border: 1px solid rgba(0, 76, 150, 0.10);\n  border-radius: 18px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  color: var(--ama-muted);\n  font-size: 14px;\n  line-height: 1.62;\n  font-style: italic;\n  box-shadow:\n    0 8px 20px rgba(0, 76, 150, 0.04),\n    inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n  margin: 28px 0;\n  padding: 24px;\n  border-radius: 22px;\n  background:\n    radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n    linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n  box-shadow:\n    0 16px 34px rgba(254, 75, 9, 0.22),\n    inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n  color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n  margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n  margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n  display: grid;\n  gap: 12px;\n  margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 18px;\n  background: rgba(255, 255, 255, 0.86);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n  cursor: pointer;\n  padding: 18px 50px 18px 18px;\n  color: var(--ama-blue);\n  font-weight: 900;\n  line-height: 1.35;\n  list-style: none;\n  position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n  display: none;\n}\n\n.ama-bsafe-faq summary::after {\n  content: \"+\";\n  position: absolute;\n  right: 18px;\n  top: 50%;\n  transform: translateY(-50%);\n  color: var(--ama-orange);\n  font-size: 24px;\n  line-height: 1;\n  font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n  content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n  padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n  margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n  margin-top: 30px;\n  padding: 24px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 24px;\n  background:\n    radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n    linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  box-shadow:\n    0 14px 34px rgba(0, 76, 150, 0.08),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n  margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  min-height: 46px;\n  padding: 12px 22px;\n  border-radius: 999px;\n  background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n  color: #ffffff !important;\n  font-weight: 900;\n  text-decoration: none;\n  box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n  margin-top: 30px;\n  padding-top: 22px;\n  border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n  margin: 0;\n  color: var(--ama-muted);\n  font-size: 13px;\n  line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n  max-width: 1180px;\n  margin: 32px auto 0;\n  padding: 24px;\n  border: 1px solid rgba(0, 76, 150, 0.18);\n  border-radius: 22px;\n  background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n  box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n  color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n  margin: 0 0 8px;\n  font-size: 13px;\n  letter-spacing: 0.08em;\n  text-transform: uppercase;\n  font-weight: 900;\n  color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n  margin: 0 0 12px;\n  color: #004c96;\n  font-size: clamp(22px, 2.4vw, 30px);\n  line-height: 1.15;\n  font-weight: 900;\n  letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n  margin: 0 0 10px;\n  line-height: 1.65;\n  color: #184b78;\n  font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n  margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n  .ama-bsafe-grid {\n    grid-template-columns: repeat(2, minmax(0, 1fr));\n  }\n\n  .ama-bsafe-substance-row {\n    display: grid;\n    grid-template-columns: 130px minmax(0, 1fr);\n    align-items: start;\n    gap: 10px 14px;\n  }\n\n  .ama-bsafe-substance-code {\n    grid-column: 1;\n    grid-row: 1;\n  }\n\n  .ama-bsafe-substance-threshold {\n    grid-column: 2;\n    grid-row: 1;\n    justify-self: start;\n    margin-left: 0;\n  }\n\n  .ama-bsafe-substance-main {\n    grid-column: 1 \/ -1;\n    grid-row: 2;\n    min-width: 0;\n    width: 100%;\n  }\n}\n\n@media (max-width: 640px) {\n  .ama-bsafe-panel {\n    border-radius: 22px;\n  }\n\n  .ama-bsafe-inner {\n    padding: 24px 14px;\n  }\n\n  .ama-bsafe-title {\n    font-size: clamp(28px, 8.4vw, 36px);\n    letter-spacing: -0.035em;\n  }\n\n  .ama-bsafe-summary-strip {\n    display: grid;\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-summary-item {\n    border-radius: 16px;\n  }\n\n  .ama-bsafe-accordion {\n    gap: 10px;\n  }\n\n  .ama-bsafe-item {\n    border-radius: 20px;\n  }\n\n  .ama-bsafe-item summary {\n    min-height: 60px;\n    padding: 12px 52px 12px 15px;\n  }\n\n  .ama-bsafe-item summary::after {\n    right: 14px;\n    width: 32px;\n    height: 32px;\n    font-size: 20px;\n  }\n\n  .ama-bsafe-item[open] summary::after {\n    font-size: 22px;\n  }\n\n  .ama-bsafe-acc-title {\n    font-size: 15px;\n    line-height: 1.18;\n    letter-spacing: -0.014em;\n  }\n\n  .ama-bsafe-acc-sub {\n    font-size: 12.2px;\n    line-height: 1.22;\n  }\n\n  .ama-bsafe-content {\n    padding: 20px 15px;\n  }\n\n  .ama-bsafe-content h2 {\n    font-size: clamp(24px, 7vw, 30px);\n  }\n\n  .ama-bsafe-grid {\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-card {\n    padding: 20px;\n  }\n\n  .ama-bsafe-substance-row {\n    padding: 16px;\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-substance-code {\n    width: fit-content;\n    min-width: 0;\n    max-width: 100%;\n  }\n\n  .ama-bsafe-substance-threshold {\n    grid-column: 1;\n    grid-row: auto;\n  }\n\n  .ama-bsafe-validation {\n    padding: 20px;\n    border-radius: 20px;\n  }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag 6T2 drogues festives\"\u003e\n  \u003cdiv class=\"ama-bsafe-panel\"\u003e\n    \u003cdiv class=\"ama-bsafe-inner\"\u003e\n      \u003cheader class=\"ama-bsafe-header\"\u003e\n              \u003cspan class=\"ama-bsafe-kicker\"\u003eTest urinario drogas festivas sin cannabis\u003c\/span\u003e\n      \n              \u003ch2 class=\"ama-bsafe-title\"\u003e\n                Drugdiag® 6T2: test urinario ketamina, MDMA, 3-MMC, opiáceos, anfetaminas y metanfetaminas\n              \u003c\/h2\u003e\n      \n              \u003cp class=\"ama-bsafe-lead\"\u003e\n                El \u003cstrong\u003etest urinario Drugdiag® 6T2\u003c\/strong\u003e, desarrollado por el \u003cstrong\u003elaboratorio francés Toda Pharma\u003c\/strong\u003e, detecta las principales \u003cstrong\u003edrogas festivas\u003c\/strong\u003e, estimulantes, disociativas y opiáceas más buscadas actualmente, \u003cstrong\u003esin incluir cannabis\u003c\/strong\u003e.\n              \u003c\/p\u003e\n      \n              \u003cp class=\"ama-bsafe-lead\"\u003e\n                Permite detectar en un solo paso la \u003cstrong\u003eketamina (KET)\u003c\/strong\u003e, la \u003cstrong\u003eMDMA \/ éxtasis\u003c\/strong\u003e, los \u003cstrong\u003eopiáceos (MOP)\u003c\/strong\u003e, la \u003cstrong\u003e3-MMC\u003c\/strong\u003e, las \u003cstrong\u003eanfetaminas (AMP)\u003c\/strong\u003e y las \u003cstrong\u003emetanfetaminas (MET)\u003c\/strong\u003e.\n              \u003c\/p\u003e\n      \n              \u003cp class=\"ama-bsafe-lead\"\u003e\n                Esta prueba urinaria responde a las necesidades de \u003cstrong\u003eparticulares\u003c\/strong\u003e, \u003cstrong\u003eprofesionales de la salud\u003c\/strong\u003e, \u003cstrong\u003eestructuras de prevención\u003c\/strong\u003e, \u003cstrong\u003eempresas\u003c\/strong\u003e y \u003cstrong\u003eactores del ambiente festivo\u003c\/strong\u003e que desean identificar rápidamente las principales familias de sustancias estimulantes, sintéticas, disociativas y opiáceas.\n              \u003c\/p\u003e\n      \n              \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003e6 familias detectadas sin cannabis\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eKET, MDMA, MOP, 3-MMC, AMP, MET\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003ePrevención, salud, fiestas y festivales\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n      \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eDetección\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003e6 drogas festivas\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eSustancias detectadas\u003c\/h2\u003e\n\n          \u003cp\u003e\n            El Drugdiag® 6T2 detecta seis familias de sustancias especialmente buscadas en contextos festivos, profesionales, médicos o de prevención, con un enfoque específico fuera del cannabis.\n          \u003c\/p\u003e\n\n          \u003cdiv class=\"ama-bsafe-substance-list\"\u003e\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003eKET\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eKetamina:\u003c\/strong\u003e ketamina, Special K, Ket, sustancia disociativa que puede alterar fuertemente la vigilancia.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003eMDMA\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eÉxtasis:\u003c\/strong\u003e MDMA, éxtasis, taz, tata, molly, sustancia estimulante y empatógena.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e500 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiáceos:\u003c\/strong\u003e morfina, heroína, opio y compuestos relacionados.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003e3-MMC\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCatinona sintética:\u003c\/strong\u003e 3-MMC, 3MMC, 3-M, sustancia estimulante frecuentemente asociada al ambiente festivo.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAnfetaminas:\u003c\/strong\u003e speed, pep, anfetaminas y estimulantes relacionados.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetanfetaminas:\u003c\/strong\u003e meth, crystal, crystal meth, ice y derivados relacionados.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n          \u003c\/div\u003e\n\n          \u003cp class=\"ama-bsafe-note\"\u003e\n            El Drugdiag® 6T2 es especialmente adecuado para la detección de las drogas festivas y estimulantes más buscadas: ketamina, éxtasis, 3-MMC, speed, crystal meth y opiáceos. No detecta cannabis.\n          \u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eUsos\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePrevención, salud, ambiente festivo\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003e¿Por qué esta prueba es especialmente útil hoy en día?\u003c\/h2\u003e\n\n          \u003cdiv class=\"ama-bsafe-grid\"\u003e\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eAmbiente festivo y policonsumo\u003c\/h3\u003e\n              \u003cp\u003e\n                En la noche, en festivales, clubes o contextos de policonsumo, las sustancias en circulación pueden incluir ketamina, MDMA, 3-MMC, anfetaminas, metanfetaminas y opiáceos. Esta prueba permite una lectura más amplia que un test limitado.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003ePrevención y comprensión del riesgo\u003c\/h3\u003e\n              \u003cp\u003e\n                En caso de duda, comportamiento inusual, malestar o sospecha de consumo, el Drugdiag® 6T2 ayuda a comprender mejor a qué familia de sustancias se puede estar enfrentando.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eProfesionales de la salud\u003c\/h3\u003e\n              \u003cp\u003e\n                La prueba puede ayudar a orientar una atención, un seguimiento o una solicitud de confirmación biológica cuando el contexto clínico lo exige.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eEstructuras festivas y actores de campo\u003c\/h3\u003e\n              \u003cp\u003e\n                Puede ser útil para estructuras de prevención, organizadores de eventos, asociaciones, equipos de reducción de riesgos y actores que enfrentan sustancias mal identificadas.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n          \u003c\/div\u003e\n\n          \u003ch3\u003ePuntos fuertes del Drugdiag® 6T2\u003c\/h3\u003e\n\n          \u003cul class=\"ama-bsafe-list\"\u003e\n            \u003cli\u003e\n\u003cstrong\u003eDetección específica:\u003c\/strong\u003e busca las principales drogas recreativas, estimulantes y opiáceos sin incluir el cannabis.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eAmplia cobertura:\u003c\/strong\u003e ketamina, MDMA, opiáceos, 3-MMC, anfetaminas y metanfetaminas.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eLectura del riesgo:\u003c\/strong\u003e ayuda a diferenciar varias familias de sustancias muy diferentes.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eResultado rápido:\u003c\/strong\u003e lectura visual en pocos minutos según el instructivo del fabricante.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eFabricante francés:\u003c\/strong\u003e dispositivo diseñado por el laboratorio Toda Pharma, n.º 1 en test de diagnóstico rápido.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eCalidad profesional:\u003c\/strong\u003e marcado CE, entorno de calidad ISO 13485 y trazabilidad de lotes.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eHerramienta de prevención:\u003c\/strong\u003e útil para particulares, profesionales de la salud, estructuras festivas y actores de campo.\u003c\/li\u003e\n          \u003c\/ul\u003e\n\n          \u003cdiv class=\"ama-bsafe-alert\"\u003e\n            \u003ch3\u003e¿Por qué estas sustancias generan tanta preocupación?\u003c\/h3\u003e\n            \u003cp\u003e\n              La ketamina, la MDMA, la 3-MMC, las anfetaminas, las metanfetaminas y los opiáceos pueden provocar efectos graves: agitación, hiperestimulación, alucinaciones, desorientación, pérdida de control, sedación profunda, depresión respiratoria o malestar severo según las sustancias y las mezclas.\n            \u003c\/p\u003e\n            \u003cp\u003e\n              Una prueba rápida permite orientar una sospecha, pero nunca reemplaza una atención médica o un análisis toxicológico de laboratorio cuando el contexto lo requiere.\n            \u003c\/p\u003e\n          \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eResultados\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eLectura e interpretación\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eLectura e interpretación\u003c\/h2\u003e\n\n          \u003cp\u003e\n            El Drugdiag® 6T2 proporciona un resultado analítico preliminar. Permite orientar rápidamente una sospecha de exposición a ciertas familias de drogas recreativas, estimulantes, disociativas u opiáceos.\n          \u003c\/p\u003e\n\n          \u003cdiv class=\"ama-inner-accordion\"\u003e\n            \u003cdetails open\u003e\n              \u003csummary\u003eResultado negativo\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Un resultado negativo indica que las familias buscadas no se han detectado por encima de los umbrales del test. Esto no garantiza la ausencia absoluta de cualquier sustancia, especialmente si la molécula presente no forma parte del panel buscado.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003eResultado positivo\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Un resultado positivo indica una reacción compatible con la presencia de una familia buscada: ketamina, MDMA, opiáceos, 3-MMC, anfetaminas o metanfetaminas. En contextos médicos, profesionales, oficiales o en disputa, se recomienda una confirmación en laboratorio.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003eResultado inválido\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Un resultado inválido puede estar relacionado con una mala manipulación, un volumen insuficiente de muestra o el incumplimiento del tiempo de lectura. En ese caso, se debe realizar un nuevo test con un dispositivo nuevo.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n          \u003c\/div\u003e\n\n          \u003ch3\u003eNombres callejeros asociados a las familias buscadas\u003c\/h3\u003e\n\n          \u003cul class=\"ama-bsafe-list\"\u003e\n            \u003cli\u003e\n\u003cstrong\u003eKET :\u003c\/strong\u003e ketamina, Special K, Ket.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eMDMA :\u003c\/strong\u003e éxtasis, taz, tata, molly.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eMOP :\u003c\/strong\u003e héro, heroína, opio, morfina.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003e3-MMC :\u003c\/strong\u003e 3-MMC, 3MMC, 3-M.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eAMP :\u003c\/strong\u003e speed, pep, anfetaminas.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eMET :\u003c\/strong\u003e meth, crystal, crystal meth, ice.\u003c\/li\u003e\n          \u003c\/ul\u003e\n\n          \u003cp class=\"ama-bsafe-note\"\u003e\n            Los nombres callejeros cambian rápidamente y nunca garantizan la composición real del producto consumido. Un mismo nombre puede designar sustancias diferentes según el lote, la región o el circuito de distribución.\n          \u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eTécnica\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eCalidad y fiabilidad\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eExperiencia técnica\u003c\/h2\u003e\n\n          \u003cdiv class=\"ama-bsafe-grid\"\u003e\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eTecnología de oro coloidal\u003c\/h3\u003e\n              \u003cp\u003e\n                El dispositivo utiliza inmunocromatografía competitiva con anticuerpos marcados con oro coloidal, permitiendo una lectura clara, rápida y adecuada para usos profesionales.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eFiabilidad GC\/MS\u003c\/h3\u003e\n              \u003cp\u003e\n                La precisión de este dispositivo profesional de detección urinaria ha sido comparada con el método de referencia en laboratorio, la cromatografía de gases acoplada a espectrometría de masas (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e).\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eConformidad de calidad\u003c\/h3\u003e\n              \u003cp\u003e\n                Diseñado por el laboratorio francés Toda Pharma, este dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e cuenta con la marca \u003cstrong\u003eCE\u003c\/strong\u003e, un entorno de calidad conforme a la norma \u003cstrong\u003eISO 13485\u003c\/strong\u003e y una trazabilidad completa de los lotes.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n          \u003c\/div\u003e\n\n          \u003ch3\u003eCaracterísticas principales\u003c\/h3\u003e\n\n          \u003cul class=\"ama-bsafe-list\"\u003e\n            \u003cli\u003e\n\u003cstrong\u003eTipo de test :\u003c\/strong\u003e test urinario orientado a drogas recreativas, estimulantes, disociativas y opiáceos.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eFamilias buscadas :\u003c\/strong\u003e KET, MDMA, MOP, 3-MMC, AMP, MET.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eParticularidad :\u003c\/strong\u003e panel específico sin cannabis.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eFormato :\u003c\/strong\u003e dispositivo urinario de lectura rápida.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eUso :\u003c\/strong\u003e prevención, salud, espacios festivos, campo, empresas y autocontrol responsable.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eFabricante :\u003c\/strong\u003e laboratorio francés Toda Pharma, n.º 1 en test de diagnóstico rápido.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eCalidad:\u003c\/strong\u003e dispositivo médico de diagnóstico in vitro con marcado CE e ISO 13485.\u003c\/li\u003e\n          \u003c\/ul\u003e\n\n          \u003ch3\u003eAusencia de reacciones cruzadas\u003c\/h3\u003e\n\n          \u003cul class=\"ama-bsafe-list\"\u003e\n            \u003cli\u003e\n\u003cstrong\u003eMedicamentos comunes:\u003c\/strong\u003e aspirina, ibuprofeno, paracetamol, amoxicilina, penicilina, dextrometorfano.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eSustancias fisiológicas y alimentarias:\u003c\/strong\u003e cafeína, colesterol, hemoglobina, creatinina, vitamina C, ácido úrico.\u003c\/li\u003e\n          \u003c\/ul\u003e\n\n          \u003cp class=\"ama-bsafe-note\"\u003e\n            La prueba debe usarse conforme al prospecto del fabricante. En caso de resultado positivo, dudoso o impugnado, se recomienda una confirmación mediante análisis de laboratorio.\n          \u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003ePreguntas frecuentes\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePreguntas frecuentes\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003ePreguntas frecuentes\u003c\/h2\u003e\n\n          \u003cdiv class=\"ama-inner-accordion\"\u003e\n            \u003cdetails open\u003e\n              \u003csummary\u003e¿La prueba detecta ketamina?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Sí. El Drugdiag® 6T2 detecta la \u003cstrong\u003eketamina (KET)\u003c\/strong\u003e con un umbral de \u003cstrong\u003e1000 ng\/mL\u003c\/strong\u003e.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003e¿La prueba detecta 3-MMC?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Sí. Detecta específicamente la \u003cstrong\u003e3-MMC\u003c\/strong\u003e con un umbral de detección de \u003cstrong\u003e1000 ng\/mL\u003c\/strong\u003e.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003e¿La prueba detecta éxtasis?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Sí. Detecta la \u003cstrong\u003eMDMA\u003c\/strong\u003e, comúnmente llamada \u003cstrong\u003eéxtasis\u003c\/strong\u003e, \u003cstrong\u003etaz\u003c\/strong\u003e o \u003cstrong\u003emolly\u003c\/strong\u003e, con un umbral de \u003cstrong\u003e500 ng\/mL\u003c\/strong\u003e.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003e¿La prueba detecta speed y crystal meth?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Sí. Detecta las \u003cstrong\u003eanfetaminas (AMP)\u003c\/strong\u003e y las \u003cstrong\u003emetanfetaminas (MET)\u003c\/strong\u003e, que corresponden a denominaciones como \u003cstrong\u003espeed\u003c\/strong\u003e, \u003cstrong\u003emeth\u003c\/strong\u003e, \u003cstrong\u003ecrystal meth\u003c\/strong\u003e o \u003cstrong\u003eice\u003c\/strong\u003e.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003e¿Por qué esta prueba no incluye cannabis?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Porque está diseñado para detectar específicamente otras familias de sustancias: ketamina, éxtasis, opiáceos, 3-MMC, anfetaminas y metanfetaminas. Por lo tanto, es pertinente cuando la necesidad se centra en drogas recreativas fuera del cannabis.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003e¿Tiene un resultado positivo un valor definitivo?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  No. Una prueba rápida proporciona un resultado analítico preliminar. En cualquier contexto oficial, médico, judicial, administrativo, disciplinario o impugnado, se recomienda una confirmación mediante método analítico de laboratorio.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n          \u003c\/div\u003e\n\n          \u003cdiv class=\"ama-bsafe-cta\"\u003e\n            \u003cp\u003e¿Necesita un consejo o un presupuesto para un pedido profesional?\u003c\/p\u003e\n            \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e\n              Solicitar un presupuesto\n            \u003c\/a\u003e\n          \u003c\/div\u003e\n\n          \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e\n            \u003cp\u003e\n              \u003cstrong\u003eAviso legal:\u003c\/strong\u003e Este dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e está destinado a un uso preventivo, profesional o personal responsable. Proporciona un resultado analítico preliminar y no sustituye un análisis toxicológico de laboratorio. En caso de resultado positivo, dudoso, impugnado o en situaciones oficiales, médicas, judiciales, administrativas o disciplinarias, se recomienda una confirmación mediante método analítico de laboratorio.\n            \u003c\/p\u003e\n          \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unidad","offer_id":56426436034884,"sku":null,"price":19.0,"currency_code":"USD","in_stock":true},{"title":"Lote de 5","offer_id":56426436067652,"sku":null,"price":94.0,"currency_code":"USD","in_stock":true},{"title":"Lote de 10","offer_id":56426436100420,"sku":null,"price":179.0,"currency_code":"USD","in_stock":true},{"title":"Lote de 25","offer_id":56426436133188,"sku":null,"price":399.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/photo_produit_drugdiag_T_NPS.png?v=1777893890","url":"https:\/\/ama-prevention.com\/es\/products\/test-urinario-drugdiag-6t2-nuevas-drogas-de-sintesis","provider":"AMA Prévention ","version":"1.0","type":"link"}